Adaptive T cell immune responses and atherogenesis

Curr Opin Pharmacol. 2010 Apr;10(2):197-202. doi: 10.1016/j.coph.2010.02.003. Epub 2010 Mar 5.

Abstract

Atherosclerosis is a chronic inflammatory disease of the arterial wall where both innate and adaptive immune responses contribute to disease initiation and progression. Initial studies have focused on the role of T helper-1 (Th1) and Th2 responses in atherosclerosis, and more recently evidence has been published supporting a protective role of regulatory T cells in this disease. A third member of the T helper set, IL-17-producing T cells, now called Th17 cells, was recently described as a distinct lineage that play important role in autoimmune diseases. Here, we review the current knowledge on the role of effector and regulatory T cell responses in atherosclerosis and discuss the contribution of the Th17 to this disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity / immunology*
  • Animals
  • Atherosclerosis / immunology*
  • Atherosclerosis / metabolism
  • Drug Discovery / methods
  • Humans
  • Inflammation Mediators / metabolism
  • Models, Immunological
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocytes, Helper-Inducer / metabolism*
  • T-Lymphocytes, Regulatory / metabolism

Substances

  • Inflammation Mediators